Literature DB >> 28551633

Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation.

Keun-Yeong Jeong1, Minhee Park2, In Un Kim3, Jae Jun Sim3, Hwan Mook Kim4.   

Abstract

BACKGROUND/AIM: 5-Fluorouracil (5-FU) over-use has led to an urgent need for alternative treatment regimens, such as a lower concentration of the drug because of its toxic effects. The aim of this study was to investigate the possibility of improving the antitumor effect of 5-FU without toxicity by targeting primary colorectal cancer (CRC) with sustained calcium supplementation.
MATERIALS AND METHODS: The viability of CRC cells was determined after treatment of 5-FU, lactate calcium salt (CaLac), or the combination of te two. Western blot analysis for the focal adhesion kinase (FAK) signaling cascade was performed to investigate the underlying mechanism. A xenograft model was established to evaluate antitumor efficacy of each treatment, and the necrotic effect was also observed in tumor tissues.
RESULTS: By the combined treatment, proteolysis of FAK signaling cascade, was mediated by sustained calcium supplementation resulting in further decrease in the clonogenicity of CRC cells. The in vivo anticancer efficacy including tumor necrosis was significantly increased by the combination treatment compared to single treatment of with 5-FU.
CONCLUSION: Sustained calcium supplementation was able to enhance the potency of 5-FU targeting the primary CRC. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  5-FU; Primary colorectal cancer; combination treatment; epithelial-mesenchymal transition; focal adhesion kinase; lactate salt

Mesh:

Substances:

Year:  2017        PMID: 28551633     DOI: 10.21873/anticanres.11649

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Antitumor Effect of Calcium-Mediated Destabilization of Epithelial Growth Factor Receptor on Non-Small Cell Lung Carcinoma.

Authors:  In Un Kim; In Sung Sung; Jae Jun Sim; Minhee Park; Keun-Yeong Jeong; Hwan Mook Kim
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

2.  Combination Antitumor Effect of Sorafenib via Calcium-Dependent Deactivation of Focal Adhesion Kinase Targeting Colorectal Cancer Cells.

Authors:  Keun-Yeong Jeong; Minhee Park; Jae-Jun Sim; Hwan Mook Kim
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.